Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CD79a Antibody Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Polyclonal
1.2.3 Monoclonal
1.3 Market by Application
1.3.1 Global CD79a Antibody Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Immunofluorescence
1.3.3 Immunohistochemistry
1.3.4 Enzyme Linked Immunosorbent Assay
1.3.5 Western Blot
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CD79a Antibody Market Perspective (2018-2029)
2.2 CD79a Antibody Growth Trends by Region
2.2.1 Global CD79a Antibody Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 CD79a Antibody Historic Market Size by Region (2018-2024)
2.2.3 CD79a Antibody Forecasted Market Size by Region (2024-2029)
2.3 CD79a Antibody Market Dynamics
2.3.1 CD79a Antibody Industry Trends
2.3.2 CD79a Antibody Market Drivers
2.3.3 CD79a Antibody Market Challenges
2.3.4 CD79a Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CD79a Antibody Players by Revenue
3.1.1 Global Top CD79a Antibody Players by Revenue (2018-2024)
3.1.2 Global CD79a Antibody Revenue Market Share by Players (2018-2024)
3.2 Global CD79a Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CD79a Antibody Revenue
3.4 Global CD79a Antibody Market Concentration Ratio
3.4.1 Global CD79a Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CD79a Antibody Revenue in 2022
3.5 CD79a Antibody Key Players Head office and Area Served
3.6 Key Players CD79a Antibody Product Solution and Service
3.7 Date of Enter into CD79a Antibody Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CD79a Antibody Breakdown Data by Type
4.1 Global CD79a Antibody Historic Market Size by Type (2018-2024)
4.2 Global CD79a Antibody Forecasted Market Size by Type (2024-2029)
5 CD79a Antibody Breakdown Data by Application
5.1 Global CD79a Antibody Historic Market Size by Application (2018-2024)
5.2 Global CD79a Antibody Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America CD79a Antibody Market Size (2018-2029)
6.2 North America CD79a Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America CD79a Antibody Market Size by Country (2018-2024)
6.4 North America CD79a Antibody Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CD79a Antibody Market Size (2018-2029)
7.2 Europe CD79a Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe CD79a Antibody Market Size by Country (2018-2024)
7.4 Europe CD79a Antibody Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CD79a Antibody Market Size (2018-2029)
8.2 Asia-Pacific CD79a Antibody Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific CD79a Antibody Market Size by Region (2018-2024)
8.4 Asia-Pacific CD79a Antibody Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CD79a Antibody Market Size (2018-2029)
9.2 Latin America CD79a Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America CD79a Antibody Market Size by Country (2018-2024)
9.4 Latin America CD79a Antibody Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CD79a Antibody Market Size (2018-2029)
10.2 Middle East & Africa CD79a Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa CD79a Antibody Market Size by Country (2018-2024)
10.4 Middle East & Africa CD79a Antibody Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific CD79a Antibody Introduction
11.1.4 Thermo Fisher Scientific Revenue in CD79a Antibody Business (2018-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 BioLegend
11.2.1 BioLegend Company Detail
11.2.2 BioLegend Business Overview
11.2.3 BioLegend CD79a Antibody Introduction
11.2.4 BioLegend Revenue in CD79a Antibody Business (2018-2024)
11.2.5 BioLegend Recent Development
11.3 FineTest
11.3.1 FineTest Company Detail
11.3.2 FineTest Business Overview
11.3.3 FineTest CD79a Antibody Introduction
11.3.4 FineTest Revenue in CD79a Antibody Business (2018-2024)
11.3.5 FineTest Recent Development
11.4 Aviva Systems Biology
11.4.1 Aviva Systems Biology Company Detail
11.4.2 Aviva Systems Biology Business Overview
11.4.3 Aviva Systems Biology CD79a Antibody Introduction
11.4.4 Aviva Systems Biology Revenue in CD79a Antibody Business (2018-2024)
11.4.5 Aviva Systems Biology Recent Development
11.5 Santa Cruz Biotechnology
11.5.1 Santa Cruz Biotechnology Company Detail
11.5.2 Santa Cruz Biotechnology Business Overview
11.5.3 Santa Cruz Biotechnology CD79a Antibody Introduction
11.5.4 Santa Cruz Biotechnology Revenue in CD79a Antibody Business (2018-2024)
11.5.5 Santa Cruz Biotechnology Recent Development
11.6 Miltenyi Biotec
11.6.1 Miltenyi Biotec Company Detail
11.6.2 Miltenyi Biotec Business Overview
11.6.3 Miltenyi Biotec CD79a Antibody Introduction
11.6.4 Miltenyi Biotec Revenue in CD79a Antibody Business (2018-2024)
11.6.5 Miltenyi Biotec Recent Development
11.7 Proteintech
11.7.1 Proteintech Company Detail
11.7.2 Proteintech Business Overview
11.7.3 Proteintech CD79a Antibody Introduction
11.7.4 Proteintech Revenue in CD79a Antibody Business (2018-2024)
11.7.5 Proteintech Recent Development
11.8 Bio-Rad
11.8.1 Bio-Rad Company Detail
11.8.2 Bio-Rad Business Overview
11.8.3 Bio-Rad CD79a Antibody Introduction
11.8.4 Bio-Rad Revenue in CD79a Antibody Business (2018-2024)
11.8.5 Bio-Rad Recent Development
11.9 Hytest
11.9.1 Hytest Company Detail
11.9.2 Hytest Business Overview
11.9.3 Hytest CD79a Antibody Introduction
11.9.4 Hytest Revenue in CD79a Antibody Business (2018-2024)
11.9.5 Hytest Recent Development
11.10 EXBIO
11.10.1 EXBIO Company Detail
11.10.2 EXBIO Business Overview
11.10.3 EXBIO CD79a Antibody Introduction
11.10.4 EXBIO Revenue in CD79a Antibody Business (2018-2024)
11.10.5 EXBIO Recent Development
11.11 NSJ Bioreagents
11.11.1 NSJ Bioreagents Company Detail
11.11.2 NSJ Bioreagents Business Overview
11.11.3 NSJ Bioreagents CD79a Antibody Introduction
11.11.4 NSJ Bioreagents Revenue in CD79a Antibody Business (2018-2024)
11.11.5 NSJ Bioreagents Recent Development
11.12 Beckman Coulter
11.12.1 Beckman Coulter Company Detail
11.12.2 Beckman Coulter Business Overview
11.12.3 Beckman Coulter CD79a Antibody Introduction
11.12.4 Beckman Coulter Revenue in CD79a Antibody Business (2018-2024)
11.12.5 Beckman Coulter Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global CD79a Antibody Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Polyclonal
Table 3. Key Players of Monoclonal
Table 4. Global CD79a Antibody Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global CD79a Antibody Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global CD79a Antibody Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global CD79a Antibody Market Share by Region (2018-2024)
Table 8. Global CD79a Antibody Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global CD79a Antibody Market Share by Region (2024-2029)
Table 10. CD79a Antibody Market Trends
Table 11. CD79a Antibody Market Drivers
Table 12. CD79a Antibody Market Challenges
Table 13. CD79a Antibody Market Restraints
Table 14. Global CD79a Antibody Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global CD79a Antibody Market Share by Players (2018-2024)
Table 16. Global Top CD79a Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD79a Antibody as of 2022)
Table 17. Ranking of Global Top CD79a Antibody Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by CD79a Antibody Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players CD79a Antibody Product Solution and Service
Table 21. Date of Enter into CD79a Antibody Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CD79a Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global CD79a Antibody Revenue Market Share by Type (2018-2024)
Table 25. Global CD79a Antibody Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global CD79a Antibody Revenue Market Share by Type (2024-2029)
Table 27. Global CD79a Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global CD79a Antibody Revenue Market Share by Application (2018-2024)
Table 29. Global CD79a Antibody Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global CD79a Antibody Revenue Market Share by Application (2024-2029)
Table 31. North America CD79a Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America CD79a Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America CD79a Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe CD79a Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe CD79a Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe CD79a Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific CD79a Antibody Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific CD79a Antibody Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific CD79a Antibody Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America CD79a Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America CD79a Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America CD79a Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa CD79a Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa CD79a Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa CD79a Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 46. Thermo Fisher Scientific Company Detail
Table 47. Thermo Fisher Scientific Business Overview
Table 48. Thermo Fisher Scientific CD79a Antibody Product
Table 49. Thermo Fisher Scientific Revenue in CD79a Antibody Business (2018-2024) & (US$ Million)
Table 50. Thermo Fisher Scientific Recent Development
Table 51. BioLegend Company Detail
Table 52. BioLegend Business Overview
Table 53. BioLegend CD79a Antibody Product
Table 54. BioLegend Revenue in CD79a Antibody Business (2018-2024) & (US$ Million)
Table 55. BioLegend Recent Development
Table 56. FineTest Company Detail
Table 57. FineTest Business Overview
Table 58. FineTest CD79a Antibody Product
Table 59. FineTest Revenue in CD79a Antibody Business (2018-2024) & (US$ Million)
Table 60. FineTest Recent Development
Table 61. Aviva Systems Biology Company Detail
Table 62. Aviva Systems Biology Business Overview
Table 63. Aviva Systems Biology CD79a Antibody Product
Table 64. Aviva Systems Biology Revenue in CD79a Antibody Business (2018-2024) & (US$ Million)
Table 65. Aviva Systems Biology Recent Development
Table 66. Santa Cruz Biotechnology Company Detail
Table 67. Santa Cruz Biotechnology Business Overview
Table 68. Santa Cruz Biotechnology CD79a Antibody Product
Table 69. Santa Cruz Biotechnology Revenue in CD79a Antibody Business (2018-2024) & (US$ Million)
Table 70. Santa Cruz Biotechnology Recent Development
Table 71. Miltenyi Biotec Company Detail
Table 72. Miltenyi Biotec Business Overview
Table 73. Miltenyi Biotec CD79a Antibody Product
Table 74. Miltenyi Biotec Revenue in CD79a Antibody Business (2018-2024) & (US$ Million)
Table 75. Miltenyi Biotec Recent Development
Table 76. Proteintech Company Detail
Table 77. Proteintech Business Overview
Table 78. Proteintech CD79a Antibody Product
Table 79. Proteintech Revenue in CD79a Antibody Business (2018-2024) & (US$ Million)
Table 80. Proteintech Recent Development
Table 81. Bio-Rad Company Detail
Table 82. Bio-Rad Business Overview
Table 83. Bio-Rad CD79a Antibody Product
Table 84. Bio-Rad Revenue in CD79a Antibody Business (2018-2024) & (US$ Million)
Table 85. Bio-Rad Recent Development
Table 86. Hytest Company Detail
Table 87. Hytest Business Overview
Table 88. Hytest CD79a Antibody Product
Table 89. Hytest Revenue in CD79a Antibody Business (2018-2024) & (US$ Million)
Table 90. Hytest Recent Development
Table 91. EXBIO Company Detail
Table 92. EXBIO Business Overview
Table 93. EXBIO CD79a Antibody Product
Table 94. EXBIO Revenue in CD79a Antibody Business (2018-2024) & (US$ Million)
Table 95. EXBIO Recent Development
Table 96. NSJ Bioreagents Company Detail
Table 97. NSJ Bioreagents Business Overview
Table 98. NSJ Bioreagents CD79a Antibody Product
Table 99. NSJ Bioreagents Revenue in CD79a Antibody Business (2018-2024) & (US$ Million)
Table 100. NSJ Bioreagents Recent Development
Table 101. Beckman Coulter Company Detail
Table 102. Beckman Coulter Business Overview
Table 103. Beckman Coulter CD79a Antibody Product
Table 104. Beckman Coulter Revenue in CD79a Antibody Business (2018-2024) & (US$ Million)
Table 105. Beckman Coulter Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CD79a Antibody Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global CD79a Antibody Market Share by Type: 2022 VS 2029
Figure 3. Polyclonal Features
Figure 4. Monoclonal Features
Figure 5. Global CD79a Antibody Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global CD79a Antibody Market Share by Application: 2022 VS 2029
Figure 7. Immunofluorescence Case Studies
Figure 8. Immunohistochemistry Case Studies
Figure 9. Enzyme Linked Immunosorbent Assay Case Studies
Figure 10. Western Blot Case Studies
Figure 11. Others Case Studies
Figure 12. CD79a Antibody Report Years Considered
Figure 13. Global CD79a Antibody Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global CD79a Antibody Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global CD79a Antibody Market Share by Region: 2022 VS 2029
Figure 16. Global CD79a Antibody Market Share by Players in 2022
Figure 17. Global Top CD79a Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD79a Antibody as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by CD79a Antibody Revenue in 2022
Figure 19. North America CD79a Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America CD79a Antibody Market Share by Country (2018-2029)
Figure 21. United States CD79a Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada CD79a Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe CD79a Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe CD79a Antibody Market Share by Country (2018-2029)
Figure 25. Germany CD79a Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France CD79a Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. CD79a Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy CD79a Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia CD79a Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries CD79a Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific CD79a Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific CD79a Antibody Market Share by Region (2018-2029)
Figure 33. China CD79a Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan CD79a Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea CD79a Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia CD79a Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India CD79a Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia CD79a Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America CD79a Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America CD79a Antibody Market Share by Country (2018-2029)
Figure 41. Mexico CD79a Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil CD79a Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa CD79a Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa CD79a Antibody Market Share by Country (2018-2029)
Figure 45. Turkey CD79a Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia CD79a Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in CD79a Antibody Business (2018-2024)
Figure 48. BioLegend Revenue Growth Rate in CD79a Antibody Business (2018-2024)
Figure 49. FineTest Revenue Growth Rate in CD79a Antibody Business (2018-2024)
Figure 50. Aviva Systems Biology Revenue Growth Rate in CD79a Antibody Business (2018-2024)
Figure 51. Santa Cruz Biotechnology Revenue Growth Rate in CD79a Antibody Business (2018-2024)
Figure 52. Miltenyi Biotec Revenue Growth Rate in CD79a Antibody Business (2018-2024)
Figure 53. Proteintech Revenue Growth Rate in CD79a Antibody Business (2018-2024)
Figure 54. Bio-Rad Revenue Growth Rate in CD79a Antibody Business (2018-2024)
Figure 55. Hytest Revenue Growth Rate in CD79a Antibody Business (2018-2024)
Figure 56. EXBIO Revenue Growth Rate in CD79a Antibody Business (2018-2024)
Figure 57. NSJ Bioreagents Revenue Growth Rate in CD79a Antibody Business (2018-2024)
Figure 58. Beckman Coulter Revenue Growth Rate in CD79a Antibody Business (2018-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed